This is in continuation of the Exchange Notice No:    20221118-2 dated Friday, November 18, 2022, Trading Members are hereby informed that Windlas Biotech Limited (Scrip code: 543329) has now informed to the Exchange about discontinuation of the Buyback of its fully paid-up equity shares of face value of Re. 5/- each from the Open Market through the trading mechanism of the Exchange w.e.f. May 03, 2023.

In case trading members require any clarification, they may contact Mr. Raghavendra Bhat on Tel. no. (022) 2272 8915.

Rupal Khandelwal

Assistant General Manager

Monday, May 08, 2023